GCBC's joint liquidators sell full stake in Cordlife Group

They hold a 9.99% stake in the company.

The joint liquidators of Global Cord Blood Corporation (GCBC) have disposed of their entire stake in the Cordlife Group.

In a bourse filing, Cordlife reported that Margot Maclnnis and John Royale of Grant Thornton Specialist Services disposed of more than 25.5 million shares or 9.99 stake in the company.

Maclnnis, Royale, and Chow Tsz Nga are joint provisional liquidators of GCBC, making them deemed interested in the shares of Cordlife.

GCBC holds an interest in Cordlife through China Stem Cells (East) Company Limited (CSCECL), which owns 25.5 million shares in Cordlife.

China Stem Cells Holdings Limited (CSCHL), for which GCBC is the sole shareholder, is also the sole shareholder of CSCECL.

Follow the link for more news on

Cordlife Group

shares acqusition

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia